ライフサイエンスコーパス: renal mass

1 in the upper pole of the kidney, mimicking a renal mass.

2 ist to review the approach to the incidental renal mass.

3 damental role in the care of patients with a renal mass.

4 atory hyperfiltration following reduction in renal mass.

5 ider percutaneous biopsy when encountering a renal mass.

6 ociated with chronic proteinuria and loss of renal mass.

7 any renal diseases and adaptation to loss of renal mass.

8 velop renal injury after severe reduction of renal mass.

9 One child also demonstrated an echogenic renal mass.

10 veins, smaller right kidney, or cystic right renal mass.

11 cally in association with reduced functional renal mass.

12 rimental renal disease in a model of reduced renal mass.

13 ive antagonist A-127722 in rats with reduced renal mass.

14 ed were all markedly modulated by changes in renal mass.

15 t on hypertension produced by a reduction in renal mass.

16 ry are down-regulated by providing increased renal mass.

17 elop methods for estimating functional donor renal mass.

18 adaptive changes that follow a reduction in renal mass.

19 before surgical resection (median 4 d) of a renal mass.

20 duction of renal mass), or sham reduction of renal mass.

21 icktly adjoined to the left kidney mimicking renal mass.

22 distinguishing between benign and malignant renal masses.

23 managing newly diagnosed patients with small renal masses.

24 plant patients who underwent nephrectomy for renal masses.

25 e ablative method for the treatment of small renal masses.

26 elpful in characterizing and differentiating renal masses.

27 tomography (CT), for the treatment of solid renal masses.

28 a basis for differential diagnosis of other renal masses.

29 has become more common for the treatment of renal masses.

30 e of percutaneous biopsy in the diagnosis of renal masses.

31 dings were similar in the majority of cystic renal masses.

32 imaging for many incompletely characterized renal masses.

33 emerged as the treatment of choice for small renal masses.

34 and in the differential diagnosis of imaged renal masses.

35 cterization, and post-operative follow-up of renal masses.

36 f many incompletely characterized incidental renal masses.

37 n with CT to characterize 31 "indeterminate" renal masses.

38 001) with integrin alphavbeta3 expression in renal masses.

39 iagnosis and staging of benign and malignant renal masses.

40 distinguishing between benign and malignant renal masses.

41 method for characterization of indeterminate renal masses.

42 c or solid renal masses and those who had no renal masses.

43 ally invasive partial nephrectomies for such renal masses.

44 best management approaches for patients with renal masses.

45 sses, nonsimple or solid renal masses, or no renal masses.

46 imally invasive surgical extirpation of cT1b renal masses.

47 ecisions on how to treat patients with small renal masses.

48 cal decision making during surgery for large renal masses.

49 rminate renal lesions, 1 patient had a solid renal mass, 1 patient had sclerotic bone metastases (alb

50 trong predictor of benignity in an exophytic renal mass 2 cm or greater in diameter with high specifi

51 MR images from 108 pathologically proved renal masses (88 clear cell RCCs and 20 minimal fat AMLs

52 Among solid renal masses, a more aggressive overall approach is take

53 he adaptive responses of remnant nephrons to renal mass ablation, these data suggest that ANP of rena

54 renal growth, suggesting that an increase in renal mass above a normal level requires the activation

55 We review the natural history of small renal masses according to the current literature, and hi

56 radiologists the lead role in the work-up of renal masses, an area where urologists once held forth.

57 I (AngII) type I receptor blocker, preserved renal mass and gross morphology of the obstructed kidney

58 n all Agt genotypes, UUO reduced ipsilateral renal mass and increased that of the opposite kidney.

59 ats subjected to a 75% surgical reduction of renal mass and normotensive sham-operated control rats.

60 ing population, the absence or presence of a renal mass and RCC were verified by abdominal CT and by

61 The signal intensity (SI) of each renal mass and spleen on opposed-phase and in-phase GRE

62 Renal function (GFR) was reduced by loss of renal mass and was reduced further in proteinuric rats w

63 Of 1159 patients with simple cyst-appearing renal masses and a minimum of 5 years of follow-up, six

64 variate logistic regression analysis for all renal masses and for small masses.

65 on-of-interest measurements were obtained in renal masses and in the gallbladder or low-density renal

66 of the imaging features of specific kinds of renal masses and more accurate imaging-guided biopsy are

67 Of 446 patients with nonsimple or solid renal masses and sufficient follow-up, 50 (11%) develope

68 gic features of neoplastic and nonneoplastic renal masses and their radiologic analogues, described a

69 with those who had nonsimple cystic or solid renal masses and those who had no renal masses.

70 onflict between those treating patients with renal masses and those with an interest in renal donatio

71 ting Bosniak category IV lesion and/or solid renal mass, and multiplicity of Bosniak III lesions were

72 nign prostatic hyperplasia, prostate cancer, renal masses, and renal calculi have resulted in enhance

73 his approach ideal for posterior and lateral renal masses, and technically feasible with the advances

74 cause a considerable fraction of small solid renal masses are benign and do not need treatment, there

75 As more renal masses are diagnosed in the elderly or comorbid pa

76 However, most renal masses are either too small to characterize comple

77 gests that a significant percentage of small renal masses are indolent and possess a low metastatic r

78 cinoma and the detection of incidental small renal masses are rising.

79 Simple cyst-appearing renal masses are unlikely to be malignant.

80 robability of malignancy in cystic and solid renal masses, are provided for two types of patients, th

81 donors with a diagnosis of incidental small renal mass before implantation and their corresponding r

82 Further, a recent renewed interest in renal mass biopsy for risk stratification in SRMs has oc

83 Two strategies were compared: renal mass biopsy to triage patients to surgery or imagi

84 Although percutaneous renal mass biopsy with cross-sectional imaging guidance

85 eviews reported experience with percutaneous renal mass biopsy, discusses the technical factors that

86 .001) was a significant predictor of benign renal mass but mass size (P = .66) was not.

87 articipate in the adaptation to reduction in renal mass by changing the steady-state distribution of

88 tive of RCC and were found to have an imaged renal mass by CT.

89 Reduction of renal mass by unilateral nephrectomy results in an immed

90 Stratification of patients with renal masses by (124)I-cG250 PET can identify aggressive

91 ealous use of radical nephrectomy for the T1 renal mass, by whatever surgical approach, must now be c

92 With imaging, most incidental renal masses can be diagnosed promptly and with confiden

93 Most incidental renal masses can be diagnosed with confidence and either

94 ery is the gold standard treatment for small renal masses confirmed malignant, ablative therapies are

95 Eighty-one cystic renal masses containing calcification in a wall or septu

96 cated homogeneous high-attenuating (> 30-HU) renal masses detected at postcontrast CT enables differe

97 these lesions, and stress the limitations in renal mass diagnosis.

98 ve a role in predicting growth rate of solid renal masses during active surveillance.

99 stage migration toward diagnosis of smaller renal masses, energy ablative techniques are being incre

100 b administration and before resection of the renal mass(es).

101 ith histologically characterized solid small renal masses, excluding lipid-rich angiomyolipomas, unde

102 ced by dietary acid and animals with reduced renal mass exhibit increased urinary ET-1 excretion, the

103 tial nephrectomy for treatment of T1b and T2 renal mass, focusing oncological and renal functional ou

104 in vivo would spare the patient with a solid renal mass from unnecessary biopsies prior to surgery, o

105 contrast-enhanced US with 1018 indeterminate renal masses from 1999 to 2010, identified initially wit

106 ave on the discovery and characterization of renal masses has been detailed in the pages of Radiology

107 Children born with reduced congenital renal mass have an increased risk of hypertension and ch

108 cades, new modalities for treatment of small renal mass have emerged but despite their evolution and

109 r, hyperfiltration damage related to reduced renal mass, have also been proposed as factors in the ca

110 n widely adopted for the management of small renal masses; however, usage in T1b (greater than 4 cm)

111 should remain the standard of care for small renal masses, if the renal tumor size and complexity are

112 n 11844 (75%), and nonsimple cystic or solid renal masses in 1182 (8%).

113 s were identified in 2669 patients (17%), no renal masses in 11844 (75%), and nonsimple cystic or sol

114 A total of 162 exophytic (2 cm or greater) renal masses in 152 patients (103 men, 49 women; mean ag

115 Images of 69 renal masses in 59 patients (38 men, 21 women; mean age,

116 are effective treatment modalities for small renal masses in the infirm patient.

117 s, we find a higher percentage of incidental renal masses in these donors as a result of the inherent

118 Common and uncommon renal masses, in concert with clinical and other imaging

119 There were 26 benign small renal masses (including 18 oncocytomas, seven lipid-poor

120 might be considered in the patient in whom a renal mass is detected in the clinical setting of infect

121 Calcification in a cystic renal mass is not as important in diagnosis as is the pr

122 e data show that the quantity of functioning renal mass is not only an important independent determin

123 Treatment selection of renal masses is informed largely by size.

124 The natural history of small renal masses is not completely understood.

125 of percutaneous biopsy for the diagnosis of renal masses is now more commonplace as urologists and r

126 The natural history of small renal masses is still largely unknown; however, initial

127 Management of T1b and T2 renal masses is transforming with adoption of partial ne

128 MR) imaging equipment, the diagnosis of most renal masses is usually straightforward and accurate.

129 ailure, who was subsequently found to have a renal mass, is described.

130 effective and preferable approach to the T1 renal mass, it remains markedly underutilized in the USA

131 s recommending partial nephrectomy for small renal masses, it is essential to understand the benefits

132 The indolent natural history of small renal masses mandates that we await 10-year data, as wel

133 easibility of RPN in the management of small renal masses, many of them in complex locations.

134 Observation of small renal masses may represent a viable clinical option.

135 ng, such as structural or functional loss of renal mass, may accelerate progression of adult polycyst

136 ell-demarcated, homogeneous high-attenuating renal masses (mean diameter, 2.5 cm; range, 1-4 cm) dete

137 age, 58.1 years) underwent MR imaging of 113 renal masses (mean diameter, 5.4 cm) with pathologic dia

138 deviation]; 31 men, 13 women) with 47 solid renal masses measuring at least 1 cm who underwent two c

139 eview as pertaining to simple cyst-appearing renal masses, nonsimple or solid renal masses, or no ren

140 retroperitoneal ganglioneuroma that mimicked renal mass on imaging.

141 among different histopathologic diagnoses in renal masses on the basis of their perfusion level.

142 the patient with either a small asymptomatic renal mass or a small hyperattenuating mass that meets t

143 ass), right uninephrectomy (50% reduction of renal mass), or sham reduction of renal mass.

144 t-appearing renal masses, nonsimple or solid renal masses, or no renal masses.

145 asses than that in nonsimple cystic or solid renal masses (P < .0001).

146 s significantly different from that of other renal masses (P < .0002); in 16 (59%) of 27 patients wit

147 %-10% were significantly higher in malignant renal masses (P = .018, P = .002, P = .036, P = .016, P

148 -appearing renal masses versus those without renal masses (P = .54).

149 However, some renal masses, particularly small ones, remain indetermin

150 e recent guidelines for the management of T1 renal masses put forth by the American Urological Associ

151 were separate from the simple cyst-appearing renal mass, rather than within it.

152 and SEL evaluation was also performed to the renal mass (RCC) of the patient.

153 Here, we investigate whether renal mass reduction affects primary cilia length and fu

154 Renal mass reduction and growth factor treatment was ass

155 els of hypertension and in mice subjected to renal mass reduction as a model of CKD.

156 tubules to redifferentiate in rats with 75% renal mass reduction associated with more severe capilla

157 Previously, it was shown that 5/6 renal mass reduction by surgical excision (RK-NX) result

158 Oxidative stress from renal mass reduction contributes to the glomerular and t

159 ermore, initially normotensive rats with 75% renal mass reduction developed hypertension and proteinu

160 In summary, severe (>50%) renal mass reduction disproportionately compromised tubu

161 the functional derangements associated with renal mass reduction in the rat.

162 Renal dysfunction after congenital renal mass reduction is associated with impaired regulat

163 ced hypertension; and early mortality in the renal mass reduction model.

164 ssed the impact of prior graded normotensive renal mass reduction on ischemia-reperfusion-induced AKI

165 after ischemia-reperfusion in rats with 75% renal mass reduction relative to other groups.

166 y failed repair of AKI in kidneys with prior renal mass reduction triggers hemodynamically mediated p

167 perfusion occurs when there is already a 50% renal mass reduction, but not when two kidneys remain in

168 To induce renal mass reduction, mice were subjected to unilateral

169 Proteinuria was unaffected by renal mass reduction.

170 protection from the progression of CRD after renal mass reduction.

171 sponsible for the initiation of GS after 5/6 renal mass reduction.

172 least in part, the renal injury attendant to renal mass reduction.

173 er and intermachine agreement-of solid small renal masses relative to the cortex in the arterial phas

174 Cryoablation of small renal masses represents an alternative method for perfor

175 dney compensation, induced by a reduction of renal mass, results in primary cilia elongation, and thi

176 summarize their approach to the diagnosis of renal masses, review the imaging findings in these lesio

177 h poles of the left kidney (75% reduction of renal mass), right uninephrectomy (50% reduction of rena

178 Rats with reduced renal mass (RRM rats) and sham-operated rats were then m

179 Twenty-six patients with renal masses scheduled for surgical resection received (

180 PURPOSE OF REVIEW: Small renal masses (SRMs) are frequently encountered due to th

181 POSE OF REVIEW: Management options for small renal masses (SRMs) include excision, ablation, and acti

182 ard of care for treatment of localized small renal masses (SRMs).

183 e management options for patients with small renal masses (SRMs).

184 s not informed of an incidental finding of a renal mass suggestive of cancer on a magnetic resonance

185 enal lesions, presence of a coexistent solid renal mass, surgical pathologic findings, and presence o

186 lower in patients with simple cyst-appearing renal masses than that in nonsimple cystic or solid rena

187 ntirely for those incompletely characterized renal masses that are highly likely to be benign cysts a

188 Today, the majority of solid renal masses that are ultimately proved to be renal cell

189 igh confidence can also be assigned to those renal masses that exhibit the radiologic analogues for h

190 progression to metastases or death for small renal masses that have undergone active surveillance (in

191 l advances in the imaging-based diagnosis of renal masses, the increased detection of incidental rena

192 ients electing radical nephrectomy for small renal masses, the kidney, following excision of the tumo

193 as led to more incidentally discovered small renal masses, the optimal treatment has evolved.

194 In hyperechoic renal masses, the presence of shadowing, a hypoechoic ri

195 In renal masses, this signal intensity loss-which is consis

196 -one patients with hematuria or a suspicious renal mass underwent CT urography, during which thinly c

197 two consecutive patients suspected of having renal masses underwent ASL MR imaging before their routi

198 range, 19-95 years; 112 men, 81 women) with renal masses underwent total or partial nephrectomy and

199 y urologic problems, including urolithiasis, renal masses, urinary tract infection, trauma, and obstr

200 dence in patients with simple cyst-appearing renal masses versus those without renal masses (P = .54)

201 rode insertion and/or repositioning into the renal mass was achieved in all cases with direct MR "flu

202 erest measurement of signal intensity of the renal mass was divided by that of reference tissue.

203 with allografts from recipients where total renal mass was reduced (by ligating branches of the graf

204 Traditionally, the treatment of suspicious renal masses was radical nephrectomy.

205 Equivalent degrees of reduction in renal mass were confirmed by the similarity of serum cre

206 Eight donors with incidental renal mass were detected (four live and four deceased do

207 Contrast enhancement features of renal masses were evaluated in terms of CT attenuation v

208 Simple cyst-appearing renal masses were identified in 2669 patients (17%), no

209 by antibody PET, and all nine non-clear-cell renal masses were negative for the tracer.

210 fore partial nephrectomy or enucleation; 205 renal masses were removed (92% were <3 cm).

211 Reports that included renal masses were selected, then categorized through man

212 Although very rare, a relatively large renal mass which shows very infiltrative growth pattern

213 tumor enucleation as a safe alternative for renal masses which are locally confined on preoperative

214 ds identified 43 patients with biopsy-proved renal masses who underwent in-phase and opposed-phase MR

215 124)I) -girentuximab PET/CT in patients with renal masses who were scheduled for resection.

216 26 patients with renal masses who were scheduled to undergo surgical rese

217 e diagnosis and management of the incidental renal mass will be suggested.

218 asses, the increased detection of incidental renal masses with cross-sectional imaging poses problems

219 Patients who had renal masses with homogeneous water attenuation, hairlin

220 A clinical study to characterize renal masses with positron emission tomography/computed

221 e for patients who had simple cyst-appearing renal masses with those who had nonsimple cystic or soli

222 e reference standards for treating the small renal mass, with laparoscopic partial nephrectomy increa